Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients

Journal of Human Hypertension

Volumn 21, Issue 3, 2007, Pages 220-224

  Fogari, R ^a   Zoppi, A ^a   Derosa, G ^a   Mugellini, A ^a   Lazzari, P ^a   Rinaldi, A ^a   Fogari, E ^a   Preti, P ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; PLACEBO; VALSARTAN;

ADULT; AGED; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MALE; MANOMETER; MONOTHERAPY; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TISSUE PRESSURE; WATER RETENTION;

ADULT; AGE FACTORS; AGED; AMLODIPINE; ANKLE; BLOOD PRESSURE; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; EDEMA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 33847044811     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002140     Document Type: Article

References (24)

1. Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens 2003; 5: 330-335.
2. Fogari R. Ankle oedema and sympathetic activation. Drugs 2005; 65(Suppl 2): 21-27.
3. Sica DA. Pharmacotherapy review: calcium channel blockers. J Clin Hypertens 2006; 8: 53-56.
4. Gustafsson D. Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 1987; 10(Suppl 1): S121-S131.
5. Salmasi AM, Belcaro G, Nicolaides AN. Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle oedema. Int J Cardiol 1991; 30: 303-307.
6. Messerli FH. Vasodilatory edema: A common side effect of antihypertensive therapy. Am J Hypertens 2001; 14: 978-979.
7. Gustaffson D, Grande PO, Borgstrom P, Lindberg L. Effects of calcium antagonists on myogenic and neurogenic control of resistance and capacitance vessels in cat muscle. J Cardiovasc Pharmacol 1988; 12: 413-422.
8. Pedrinelli R, Dell'Olmo G, Melillo E, Mariani M. Amlodipine, enalapril and dependent leg edema in essential hypertension. Hypertension 2000; 35: 621-625.
9. Guazzi MD, De Cesare N, Galli C, Salvioni A, Tramontana C, Tamborini G et al. Calcium channel blockade with nifedipine and angiotensin converting enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. Circulation 1984; 80: 279-284.
10. Kuschnir E, Acuna E, Sevilla D. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg comapred with amlodipine 5 mg, benazepril 20mg and placebo. Clin Ther 1996; 18: 1213-1223.
11. Gradman AH. for the Enalapril-Felodipine ER Factorial Study Group combined enalapril and felodipine extended release (ER) for systemic hypertension. Am J Cardiol 1997; 79: 431-435.
12. Messerli FH, Oparil S, Feng Z. Comparison of the efficacy and side-effects of combination therapy of angiotensin converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol 2000; 86: 1182-1187.
13. Fogari R, Malamani GD, Zoppi A, Mugellini A, Rinaldi A, Vanasia A et al. Effect of benazepril addition to amlodipine an ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2003; 17: 207-212.
14. Weir M, Rosenberger C, Fink JC. Pilot study to evaluate a water displacement tecnique to compare effects of diuretics and ACE-inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens 2001; 14: 963-968.
15. Hansson L, Hedner T, Dahlof B. Prospective, Randomised, Open, Blinded End point (PROBE) study: A novel design for intervention trials.. Blood Press 1992; 1: 113-114.
16. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.. J Hypertens 2003; 21: 1011-1053.
17. Lauderer A. Die gewebspannung in ihren Einfluss anf die Ortliche Blut-vud Lymphbewegung. Fogel FCW: Leipzig, 1884, 174 p.
18. Burch GE, Sodeman WA. The estimation of subcutaneous pressure by direct method. J Clin Invest 1937; 16: 845-850.
19. Malamani V. Modificazioni della pressione dei tessuti nell'edema provocato. Boll Soc Ital Biol Sper 1947; 23: 125-131.
20. Malamani V. La pressione dei tessuti. Tipografia Popolare: Pavia (Italy), 1957 p 485.
21. Fogari R, Malamani GD, Zoppi A, Preti P, Vanasia A, Fogari E et al. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind randomized, parallel-group study. Curr Ther Res 2000; 61: 850-862.
22. Mac Gregor GA, Viskoper JR, Antonios TFT, He FJ, on behalf of the UK and Israel Candesartan Investigators. Efficacy of Candesartan Cilexitil alone or in combination with amlodipine and hydrochlorothiazide in moderate to severe hypertension. Hypertension 2000; 36: 454-460.
23. Kuschnir E, Bendersky M, Resk J, Panart MS, Guzman L, Plotquin Y et al. Effects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension. J Cardiovasc Pharmacol 2004; 43: 300-305.
24. Chrysant SG, Chrysant GS. The pleiotropic effects of angiotensin receptor blockers. J Clin Hypertens 2006; 2003; 261-268.